Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 68 citing articles:

Ozoralizumab: First Approval
Susan J. Keam
Drugs (2022) Vol. 83, Iss. 1, pp. 87-92
Open Access | Times Cited: 59
Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort
Takayuki Fujii, Koichi Murata, Hideo Onizawa, et al.
Arthritis Research & Therapy (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 10
Real-World Safety and Efficacy of Targeted Therapies in Rheumatoid Arthritis: A 5-Year, 5130-Case Follow-Up from FIRST Registry
Koshiro Sonomoto, Shingo Nakayamada, Hiroaki Tanaka, et al.
Rheumatology and Therapy (2025)
Open Access | Times Cited: 1
Consensus statement on the management of late-onset rheumatoid arthritis
Masayo Kojima, Takahiko Sugihara, Yutaka Kawahito, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 6, pp. 1095-1102
Closed Access | Times Cited: 6
Therapeutic Equivalence of Biosimilar and Reference Biologic Drugs in Rheumatoid Arthritis
Bruna de Oliveira Ascef, Matheus Oliveira de Almeida, Ana Cristina de Medeiros Ribeiro, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2315872-e2315872
Open Access | Times Cited: 15
Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication
Hideto Kameda, Kunihiro Yamaoka, Yuji Yamanishi, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 1, pp. 1-10
Open Access | Times Cited: 14
Trends in treatment for patients with late-onset rheumatoid arthritis in Japan: Data from the NinJa study
Toshihiro Matsui, Tomoya Yoshida, Takahiro Nishino, et al.
Modern Rheumatology (2024)
Closed Access | Times Cited: 5
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database
Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, et al.
RMD Open (2024) Vol. 10, Iss. 2, pp. e003885-e003885
Open Access | Times Cited: 5
Comparison of effectiveness of methotrexate in patients with late-onset versus younger-onset rheumatoid arthritis: Real-world data from an inception cohort in Japan (NICER-J)
Shuji Asai, Mochihito Suzuki, Ryota Hara, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 5, pp. 892-899
Closed Access | Times Cited: 4
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry
Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, et al.
Rheumatology and Therapy (2024) Vol. 11, Iss. 3, pp. 709-736
Open Access | Times Cited: 4
Baricitinib dose reduction in patients with rheumatoid arthritis achieving sustained disease control: Final results from the RA-BEYOND study
Christopher Edwards, Gerhard Krönke, Jérôme Avouac, et al.
The Journal of Rheumatology (2025), pp. jrheum.2024-0906
Closed Access
A feasible treatment strategy for tapering subcutaneous tocilizumab in giant cell arteritis: a 24-month multi-center retrospective study
Takanori Ito, Sho Fukui, Fumika N. Nagase, et al.
Rheumatology International (2025) Vol. 45, Iss. 3
Closed Access
Factors Associated With Hallux Valgus Progression in Patients With Rheumatoid Arthritis: Insights From Non‐Weight‐Bearing Radiographs in the KURAMA Cohort
Tatsuhito Ikezaki, Koichi Murata, Takayuki Fujii, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Potential of a Novel Patient-Reported Outcome Assessment Method Utilizing Illustrations in Rheumatoid Arthritis
Kensuke Koyama, Ryousuke Koizumi
Cureus (2025)
Open Access
Treatment sequencing in inflammatory bowel disease : towards clinical precision medicine
Léa Sequier, Bénédicte Caron, Sailish Honap, et al.
Best Practice & Research Clinical Gastroenterology (2025), pp. 101994-101994
Closed Access
Iguratimod, a Promising Therapeutic Agent for COVID-19 that Attenuates Excessive Inflammation in Mouse Models
Seiya Oba, Tadashi Hosoya, Daisuke Kawata, et al.
European Journal of Pharmacology (2025), pp. 177537-177537
Closed Access
Patients’ Experiences Following Osteoarticular Foot Surgery for Rheumatoid Arthritis-Related Deformities: A Qualitative Study
Amparo Campos-Cano, Ana Belén Ortega‐Ávila, Salvador Díaz‐Miguel, et al.
Medicina (2025) Vol. 61, Iss. 4, pp. 677-677
Open Access
Characterization of patients with rheumatoid arthritis not using biologic/targeted synthetic disease-modifying drugs despite insufficient disease control: Another difficult-to-treat RA
Hisakata Yamada, Ryosuke Tsurui, Masakazu Kondo, et al.
Modern Rheumatology (2025)
Closed Access
Comparable Clinical Effectiveness of Baricitinib and Filgotinib in Patients With Rheumatoid Arthritis
Hironobu Kosugiyama, Shuji Asai, Kenya Terabe, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 5
Closed Access
Subcutaneous injection of methotrexate: Advantages in the treatment of rheumatoid arthritis
Yoshiya Tanaka
Modern Rheumatology (2022) Vol. 33, Iss. 4, pp. 633-639
Open Access | Times Cited: 15
Assessment of oral methotrexate intolerance in Japanese adult patients with rheumatoid arthritis
Masatoshi Kanda, Mayumi Sato, Ken Nagahata, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 1
Closed Access | Times Cited: 3
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis
Takahiko Sugihara, Yutaka Kawahito, Yuko Kaneko, et al.
Modern Rheumatology (2024) Vol. 34, Iss. 5, pp. 867-880
Open Access | Times Cited: 3
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis
Keisuke Tanaka, Ayako Ichikawa, Natsuka Umezawa, et al.
Cancer Science (2023) Vol. 114, Iss. 9, pp. 3719-3727
Open Access | Times Cited: 8
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
Hiroya Tamai, Kei Ikeda, Toshiaki Miyamoto, et al.
The Lancet Rheumatology (2023) Vol. 5, Iss. 4, pp. e215-e224
Open Access | Times Cited: 7
Recommendations for the management of the vascular involvement in Behçet’s disease by the Japanese National Research Committee for Behçet’s disease—secondary publication
Hiroko Nagafuchi, Hirotoshi Kikuchi, Hiroyuki Ishibash, et al.
Modern Rheumatology (2023) Vol. 34, Iss. 1, pp. 182-193
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top